As sedative (soothing), anxiolytic (anti-anxiety) and hypnotics:
- dementia including dementia due to epilepsy) that occurs with manifestations of psychomotor agitation, anxiety affect (as part of combination therapy);
- organic anxiety disorder (in the form of monotherapy or as part of combination therapy);
- schizophrenia (with prevalence of neurosis-like disorders, as part of combination therapy);
- mood disorders (affective disorders) - as part of a combination therapy;
- generalized anxiety disorder (as part of combination therapy);
- obsessive-compulsive disorder (as part of combination therapy);
- response to severe stress and adaptation disorders (acute reaction to stress, post-traumatic stress disorder, unspecified response to severe stress, other reactions to severe stress) - as part of combination therapy;
- dissociative (conversion) disorders (as part of combination therapy);
- somatoform disorders (somatization disorder, undifferentiated, somatoform disorder, hypochondriacal disorder, somatoform dysfunction of the autonomic nervous system, stable somatoform pain disorder, unspecified somatoform disorder, other somatoform disorders) - in combination therapy with severe anxiety or with ineffective standard therapy;
- unspecified disorder of the autonomic nervous system, other disorders of the autonomic nervous system (as part of combination therapy);
- anorexia nervosa (as part of combination therapy);
- emotionally unstable personality disorder (impulsive and borderline types) - as part of combination therapy;
- hysterical personality disorder, anxious (evading, avoiding)frompersonality structure (as part of combination therapy);
- persistent personality change after the experience of the disaster (as part of combination therapy);
- hyperkinetic behavior disorder (as part of combination therapy);
- behavioral disorder confined to the family (as part of combination therapy with ineffectiveness of standard therapy);
- non-specialized behavior disorder (in the form of monotherapy or as part of a combination therapy.);
- anxiety, arousal and other symptoms and signs related to the emotional state (as part of combination therapy);
- other neurotic disorders (neurasthenia, unspecified neurotic disorder) - as part of combination therapy;
- insomnia of inorganic etiology (as part of combination therapy with ineffectiveness of standard therapy);
- emotional disorders, the beginning of which is specific for childhood (phobic anxiety disorder in childhood, social anxiety disorder in childhood, frustration due to sibling (with siblings) rivalry, unspecified emotional disorder in childhood, other emotional disorders in childhood) - as part of combination therapy.
As an antiallergic agent:
- itching regardless of place and etiology (itching of the anus, itching of the vulva, unspecified anogenital itching, pruritus with photocontact dermatitis and solar urticaria, dermatitis, eczema, urticaria, bites or stings with non-venomous insects or other non-venomous arthropods, chicken pox, measles, Hodgkin's disease, diabetes mellitus, shingles) in the form of monotherapy or as part of a combination therapy;
- asthma, hay fever, whooping cough (as part of complex therapy as an antiallergic agent for cough relief, dyspnea and attacks of suffocation);
- unspecified allergy as a monotherapy or as part of a combination therapy).